Clinical trial
A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal…
NCT00001894 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001894 |
|---|---|
| Title | A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy |
| Official title | A Randomized Prospective Comparison of DDD Chamber Pacing and Percutaneous Transluminal Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Associated With Severe Drug-Refractory Symptoms |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertrophic Cardiomyopathy |
| Intervention type | Procedure |
| Interventions | pacemaker implantation, percutaneous transluminal septal ablation (PTSA) |
| Enrollment | 70 |
| Start date | Aug 1, 1999 |
| Completion | Sep 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 4, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: